Lake Shore Gazette

Leading News Website

Atrophic Scar Treatment Market is Anticipated to reach beyond US$ 6.5 Bn by the end of 2027

Atrophic Scar Treatment Market 2022

New Study Reports “Atrophic Scar Treatment Market 2022, Analysis, Growth, Size, Trends Forecasts 2027″ has been Added on PMR.

Report Overview

Starting with the overview of the Atrophic Scar Treatment Market, it presents an overall analysis of the latest trends that are prevalent in the industry. The report begins with the description of the market surroundings and the analysis of the size and forecast of product or service based on regions and applications. In addition to it, the report also introduces the market competitive landscape among the vendors and manufacturers that contribute to the growth of the product or service. The company profiling and market price analysis in relation to the value chain features is also covered in the report. The data experts have examined and scrutinized the industry trends in the key regions. 2022 has been considered as the base year, with the forecast period extending to 2030.

According to a recently conducted research by Persistence Market Research titled “Atrophic Scar Treatment Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025,” the global atrophic scar treatment market is expected to witness moderate growth during an eight-year forecast period 2017-2025. Over the assessment period, the market is likely to thrive at a CAGR of 4.6%. In 2017, global sales of atrophic scar treatments registered revenue worth a value of US$ 4.65 Bn in 2017, which is anticipated to reach beyond US$ 6.5 Bn by the end of 2027.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/22468

Popularity of lasers and injectables will surge over the years, compared to other product types such as topical scar products and surface treatment. Although topical scar products will retain dominance during 2017-2025 with more than 50% market value share, a gradual decline can be observed with time. While laser therapy is foreseen to emerge popular among wealthy consumers, injectable products will also witness a positive market outlook. Higher treatment costs will persist as a major adoption challenge though”, reports a healthcare market research analyst at Persistence Market Research.

Company Profiles: 

  • Merz Inc.
  • Enaltus LLC
  • Oculus Innovative Sciences Inc.
  • CCA Industries Inc.
  • Cynosure Inc.
  • LUMENIS
  • Syneron Medical Ltd.
  • NutraMarks Inc.
  • Mölnlycke Health Care
  • Pacific World Corporation
  • Valeant Pharmaceuticals International Inc
  • Shanghai Fosun Pharmaceuticals Ltd(ACAlma Lasers)
  • Beijing Toplaser Technology Co. Ltd
  • Sonoma Pharmaceuticals Inc.
  • Others.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/22468

atrophic scar treatment market

When it comes to end-user analysis, hospitals are expected to remain dominant with over 35% market value share in 2025. Clinics and pharmacies and drug stores are anticipated to witness stable growth, whereas E-Commerce is likely to emerge popular owing to increasingly growing adoption of online technologies by consumers worldwide.

In addition to growing demand for atrophic scar treatment, the market will experience a major thrust from the changing regulatory landscape in both developed and developing countries. Growing prevalence of skin disorders, increasing demand for sophisticated treatments, persistent product innovations, higher preference for personal care, and surging demand for age-defying treatments are also identified to predominantly fuel revenue growth of the global atrophic scar treatment market.

The regional assessment of global atrophic scar treatment market indicates continued dominance of the North America regional market, followed by Asia Pacific and Europe. By the end of 2025, the North America market for atrophic scar treatment is foreseen to exceed a value of US$ 2.6 Bn. APAC will be led by China, India, and Japan, whereas the Latin America market will be spearheaded by Brazil. Latin America is expected to emerge as the fastest growing regional market for atrophic scar treatment in the coming years.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/22468

Key Players to Focus on Direct Feedback Analysis to Incorporate “Voice of Customer”

Among the key players operating in the global landscape of atrophic scar treatment, maximum companies are identified to concentrate more on the direct feedback analysis strategy in a bid to incorporate the “voice of customer”. Others are focusing on enhancing their core competencies and gaining an expanded market share by launching new products in the marketplace. Some of the leading companies include Smith & Nephew Inc., Merz inc., CCA Industries Inc., Avita Medical Limited, Occulus Innovative Sciences, Inc., Pacific World Corp., Valeant Inc., Enaltus LLC, Molnlycke Health Care, Cynosure, Inc., Sonoma Pharmaceuticals, Inc., Shanghai Fosun Pharmaceuticals (Alma Lasers), and LUMENIS.

Key insights

  • The global market value for atrophic scar treatment is expected to register 1.3x growth during 2017-2025
  • Topical scar treatment products may lose popularity gradually, owing to growing consumer preference for laser therapies and injectable products
  • North America’s dominance is expected to prevail; however, Latin America will witness the fastest growth

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *